Currently out of the existing stock ratings of Kyle Bauser, 34 are a BUY (97.14%), 1 are a HOLD (2.86%).

Kyle Bauser

Work Performance Price Targets & Ratings Chart

Analyst Kyle Bauser, currently employed at B. RILEY, carries an average stock price target met ratio of 60.71% that have a potential upside of 47.37% achieved within 186 days. Previously, Kyle Bauser worked at LAKE STREET.

Kyle Bauser’s has documented 71 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ELMD, Electromed at 21-Jul-2025.

Wall Street Analyst Kyle Bauser

Analyst best performing recommendations are on CEMI (CHEMBIO DIAGNOSTICS).
The best stock recommendation documented was for CLPT (CLEARPOINT NEURO) at 8/8/2024. The price target of $10.5 was fulfilled within 7 days with a profit of $1.44 (15.89%) receiving and performance score of 22.71.

Average potential price target upside

of $13.72 (15.66%) on UFPT (UFP TECHNOLOGIES).
of $12.89 (21.9%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $7.95 (95.7%) on ELMD (ELECTROMED).

CEMI Chembio Diagnostics APYX Apyx Medical BIOL BIOLASE SIEN Sientra PFMT Performant Financial UFPT UFP Technologies ELMD Electromed STRM Streamline Health Solutions VREX Varex Imaging Corp SPOK Spok Holdings CLPT Clearpoint Neuro INSP Inspire Medical Systems MYO Myomo OPRX OPTIMIZERx Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kyle Bauser (LAKE STREET)